ArticleBMC medical research methodology2025
Adaptive designs for trials aiming to optimise implementation strategies and the effect of an additional interim analysis: a simulation study.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Trials that aim to optimise the implementation of an intervention are often complex, requiring multiple, combined strategies and requiring uptake on multiple levels. Previous implementation trials have optimised implementation strategies using multi-arm cluster randomised control trials (cRCTs) but can be inefficient and waste resources. Adaptive designs may potentially improve efficiency of these trials, but under what design features and trial properties is unknown. A simulation study was performed to assess under what conditions, if any, one or two interim adaptive designs offer increased efficiency compared to a 'fixed trial' approach for implementation cRCTs. A four-arm cRCT was simulated with varied trial properties, with a fixed design or an adaptive design (varying by number of interim analyses and timing of interim analyses) and modelled using Bayesian hierarchical models. The adaptive design allowed for stopping early for futility and dropping an arm for futility. The power, type 1 error rate, and adaptive design decisions were compared between the designs across trial properties. Both one and two interim adaptive designs offered power gains and a lower type 1 error rate compared to the fixed designs across most trial properties. A high intra-class correlation (ICC) of 0.2 led to adaptive trials dropping effective arms or incorrectly stopping for futility more frequently, with the incorrect decisions being compounded when two interim analyses were used. The rate of these incorrect decisions was reduced when the first interim analysis in the two interim designs was delayed. Adaptive designs can offer improved efficiency, more power, and reduce resource wastage for trials compared to fixed designs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.